Sales@Broadpharm.com
858-677-6760
Login
Cart
Home
Products
Categories
Applications
PEG Linkers
Click Chemistry Reagents
ADC Linkers
Antibody Drug Conjugates (ADC), Oncology API
Thiol Reactive Linkers
Amine Reactive Linkers
Target-Specific Linkers
Polymer PEG, Copolymer
Lipids In Drug Delivery
Nucleoside, Nucleotide, Phosphoramidite
Amino Acid, Peptide
PROTAC
Fluorescent Dye
Biotinylation reagents
Bioconjugation Kits
NEW
PEG Linkers
Acrylate PEG
BCN-PEG
Boc-PEG
Diketone Linkers
Fluorescent reagent
Iodo PEG
Non-PEG linker
PEG Hydrazide
PEG Silane
Poly PEG
TCO-PEG
Alkyne PEG
Benzyl-PEG
Branched PEG
Disulfide Linkers
Fluorine PEG
Lipid PEG
NOTA reagent
PEG NHS ester
PEG Sulfonic acid
Propargyl PEG
Tetrazine-PEG
Amino PEG
Biotin PEG
Bromo PEG
DNP-PEG
Fmoc PEG
m-PEG
PEG Acid
PEG PFP ester
PEG Tosylate
PROTAC Linker
Thiol PEG
Aminooxy PEG
Bis-PEG-acid
Chloro PEG
DOTA reagent
Hybrid Linkers
Maleimide Linkers
PEG Aldehyde
PEG Phosphonate
PEG-X-PEG
SPDP PEG
APN PEG
Bis-PEG-NHS
DBCO PEG
Enzymatically Cleavable Linkers
Hydroxy PEG
MeNH-PEG
PEG Azide
PEG PNP carbonate
Photocleavable Linkers
Sugar PEG
PEGylation of Protein, Peptide & Oligo
Antibody Drug Conjugates
Drug Delivery, Surface Modification
PROTAC
Proteomics
Amine Reactive
Bis-PEG-acid
Bis-PEG-acid
Bis-PEG-NHS
Bis-PEG-NHS
Boc-PEG
Fmoc PEG
PEG Acid
PEG Acid
PEG Aldehyde
PEG Aldehyde
PEG NHS ester
PEG NHS ester
PEG PFP ester
PEG PFP ester
PEG Phosphonate
PEG Silane
PEG Tosylate
PEG Tosylate
Poly PEG
Carbonyl Reactive
Aminooxy PEG
Carboxyl and Active ester Reactive
Amino PEG
Click Chemistry Reactive
Alkyne PEG
BCN-PEG
DBCO PEG
PEG Azide
TCO-PEG
Tetrazine-PEG
Lipid Molecules
Branched Lipid
Cationic Lipid
Cholesterol
Helper Lipid
Ionizable Lipid
PEG Lipid
Phospholipid
Multi-arm PEG
Branched PEG
Thiol Reactive
Bromo PEG
Bromo PEG
Maleimide Linkers
Maleimide Linkers
Services
Order
Support
Custom Service
Protocols
QA/QC
Magic Link Guide
Works Cited
About
Company Info
News
Blog
Customer Feedback
Careers
Contact
United States
Distributors
Login
Cart
Mogamulizumab Biosimilar, CCR4 Monoclonal Antibody
Home
/
Products
/
Antibody Drug Conjugates (ADC), Oncology API
/
Antibody
/
Mogamulizumab Biosimilar, CCR4 Monoclonal Antibody
Mogamulizumab Biosimilar, CCR4 Monoclonal Antibody
Catalog #: bp-50567
Catalog #
Unit
Price
Qty
BP-50567
1 mg
$290.00
BP-50567
5 mg
$950.00
Usually ships within 24 hours.
Would you like to inquire about custom quantity?
Inquire
Overview
Mogamulizumab Biosimilar uses the same protein sequences as the therapeutic antibody mogamulizumab. Mogamulizumab is a humanized monoclonal antibody (mAb) directed against CC chemokine receptor 4 (CCR4) for the treatment of Mycosis Fungoides (MF) and Sézary Syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma. Cutaneous T-cell lymphomas occur when certain white blood cells, called T cells, become cancerous; these cancers typically affect the skin, causing various types of skin lesions. Mogamulizumab is derived from Kyowa Hakko Kirin's POTELLIGENT technology, which produces antibodies with enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity. Mogamulizumab selectively binds to and inhibits the activity of CCR4, which may block CCR4-mediated signal transduction pathways and, so, chemokine-mediated cellular migration and proliferation of T cells, as well as chemokine-mediated angiogenesis. Additionally, this agent may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against CCR4-positive T cells. CCR4, a G-coupled-protein receptor for C-C chemokines such MIP-1, RANTES, TARC and MCP-1, is expressed on the surfaces of some types of T cells, endothelial cells, and certain types of neurons. CCR4, also known as CD194, may be overexpressed on adult T-cell lymphoma (ATL) and peripheral T-cell lymphoma (PTCL) cells. In addition to directly targeting malignant T cells expressing CCR4, mogamulizumab depletes Treg cells, an important therapeutic target in many human cancers because of their role in suppressing host antitumor immunity.
Product Details
Species Reactivity
Human
Source
Mammalian cells
Host/Isotype
Human IgG1 kappa
Class
Monoclonal
Type
Antibody
Immunogen
The human CC chemokine receptor 4 (CCR4)
Clone
Mogamulizumab Biosimilar
Conjugate
Unconjugated
Purity
>95%
Molecular Weight
146.44 kDa
Protein Concentration
1 mg/ml
Formulation
Liquid
Storage Condition
4°C for short time, -20°C or -80°C for long time.
Storage Buffer
0.2 uM filtered PBS solution, pH 7.4
Images
Datasheets and Documents
Datasheet BP-50567.pdf
Other Related Products
Trastuzumab (Anti-HER2)
Gemtuzumab (Anti-Siglec-3 / CD33)
Disitamab (Anti-ERBB2 / HER2 / CD340)
Belantamab (Anti-TNFRSF17 / BCMA / CD269)